The HinduHealth
Cancer drug price cuts expose excessive pricing, experts say
India’s regulator cut prices for 543 cancer medicine brands, effective November 9. Experts say limiting trade margins is not enough: life-saving treatment should be affordable based on medical need, not a patient’s ability to pay.
This card is an AI-assisted summary of reporting published by The Hindu. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.